| Dec'19 | Sep'19 | Jun'19 | Dec'18 | Sep'18 | Jun'18 | |
|---|---|---|---|---|---|---|
Operating expenses | ||||||
General and administrative | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Accretion Expense | ||||||
0 | 0 | - | - | - | - | |
Total operating expenses | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Operating income (loss) | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Non-operating (income) expense | ||||||
Loss from Equity Method Investment in the Joint Venture | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
(Gain) Loss on Sale of Interests in the Joint Venture | ||||||
- | - | - | 0 | 0 | 0 | |
Management fee income | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Interest expense | ||||||
0 | 0 | - | - | - | - | |
Interest income | ||||||
0 | 0 | - | - | - | - | |
Amortization of debt discount and issuance costs | ||||||
0 | 0 | - | - | - | - | |
Unrealized (gain) loss on forward purchase contract | ||||||
0 | 0 | - | - | - | - | |
Total non-operating (income) expense | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Income (loss) before income tax provision (benefit) | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Income tax provision (benefit) | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Net income (loss) | ||||||
0 | 0 | 0 | 0 | 0 | 0 | |
Net income (loss) per share: | ||||||
Basic | ||||||
0.35 | -0.66 | -0.50 | -0.16 | -0.25 | -0.23 | |
Diluted | ||||||
0.35 | -0.66 | -0.50 | -0.16 | -0.25 | -0.23 | |
Weighted average shares (see Note 5): | ||||||
Basic | ||||||
143,392 | 142,223 | 75,474 | 75,465 | 75,506 | 75,604 | |
Diluted | ||||||
146,201 | 142,223 | 75,474 | 75,465 | 75,506 | 75,604 | |